A detailed history of Principal Financial Group Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 17,576 shares of BVS stock, worth $195,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,576
Holding current value
$195,796
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$5.73 - $11.95 $100,710 - $210,033
17,576 New
17,576 $210,000
Q2 2022

Aug 10, 2022

BUY
$6.82 - $13.82 $74,985 - $151,950
10,995 New
10,995 $75,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $687M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.